Abavelisi bamachiza e-generic baholela icandelo
Igama lomenzi webhanki ligcina iminyaka engama-20, kwaye xa loo mvume iphakanyisiwe, izithako ziyafumaneka kubavelisi abavelisayo abanokukwazi ukuvelisa zabo iinguqulelo kwezo zonyango kwindawo yokuthengisa.
Iinkampani zomshuwalense ziye zenza izigulane malunga neendlela ezikhethiweyo ngokunikezela ngeefowuni eziphantsi.
Ingxelo ye-GlobalData ithi abavelisi be-Indian generic benza ngokukodwa kwiimarike ze-generics, kwaye iinkampani ezininzi kunye nokunyusa amaziko abo okuvelisa ngaphesheya ukunciphisa iindleko.
Ngokutsho kwe-US Food and Drug Administration, izidakamizwa eziqhelekileyo zinezithako ezifanayo ezisebenzayo, zisebenza ngendlela efanayo, kwaye zibonelela ngeenqobo zeeklinikhi njengama-brand-name counterparts. Oku akuthethi ukuba iziyobisi zendalo zilingana neepesenti ezili-100 ezilinganayo kunye nabalingani begama labo, kodwa abavelisi babo kufuneka babonise i-FDA ukuba banokuthi bangene endaweni efanelekileyo yezilwanyana abazikhuphelayo.
Ngokusekelwe kumanani emali anikezelwe ngoVavanyo ngo-2016, ezi nkampani zonyango zikhokela indlela kwiimarike ze-generics.
Teva Pharmaceutical Industries
Imali engenayo ingxelo ngo-2016 yayiyi-9.8 yezigidigidi zeedola.
I-Teva ihlala irekhoda ngaphezu kweeyure eziyi-9 zamaRandi ekuthengiseni kwaye ithenge amalungelo kwi-Allergan's generic division in 2015.
Mylan Inc.
Ingxelo ye-$ 9.4 yezigidigidi kwiingeniso ze-2016. Ngonyaka we-2014, ithathe inxalenye enkulu yebhizinisi le-Abbott Pharmaceutical, ukuthenga amalungelo angaphezu kwama-100 okhethekileyo kunye namayeza avelisayo.
Ekwase-United States, kunabasebenzi abangaphezu kwama-20,000 emhlabeni jikelele.
I-Sandoz, ulwahlulo lwe-generar ka-Novartis
Ingxelo yezigidigidi ezingama-9 zivakaliswe kwingeniso ngo-2016. I-Sandoz isebenzisa abasebenzi abangaphezu kwama-25,000 emhlabeni wonke kwaye isebenza kumaziko angama-30 okuvelisa.
Pfizer
Ivakalise i-$ 4.5 billion kwiingeniso ngo-2016. Eyaziwayo kakhulu ngokuphuhlisa iViagra, iPfizer yaqalisa ukuthengisa inguqu yayo yesiqhelo xa i-patent yayo iphelelwe ngo-2017.
I-Sun Pharmaceutical Industries
Ivakalise i-3.6 yezigidigidi zeerandi kwi-2016 kwaye yabona ukunyuka kweepesenti ezingama-68 kwingeniso yeziyobisi, ngenxa yenxalenye enkulu kwi-$ 4 billion yokuthengwa kwe-Ranbaxy Laboratories. Ukuthengwa kwongeze i-$ 2 yezigidigidi kwiingeniso kunye nokuqinisa i-Sun njengenkokheli kwindawo yokuthengisa yemveliso. Ilanga linabasebenzi abangaphezu kwama-30,000.
Fresenius Kabi
Ivakalise i-$ 2.8 yezigidigidi kwiingeniso ngo-2016. Inkampani yaseCanada igxile kwi-teknoloji ye-infusions, i-transfusion, kunye ne-parenteral (intravenous) yesondlo.
Endo International
Ukuxela i-$ 2.5 billion kwiingeniso ngo-2016. Ukwahlula kwe-generics yi-Par Pharmaceuticals, kunye nePAR emele "Abantu abaphumelela kwiziphumo." Inkampani yaqala ngo-1997 emva kokufumana amalungelo nezinto ezivela kwiDuPont Merck Pharmaceutical Company.
Lupine
Ivakalise i-$ 2.5 billion kwiingeniso ngo-2016.
I-Lupine yangena kwiimarike ze-generics ngo-2003 kunye ne-antibacterial drug Cefuroxime Axetil. Ngo-2018, i-Lupine ivelisa izidakamizwa ezingaphezu kwama-75.
Sanofi
Ivakalise i-$ 2 yezigidigidi kwingeniso ngo-2016. Isebenza kwimveliso yehlabathi jikelele i-Zentiva, iMedley, iGenfar, iWinthrop kunye ne-Globalpharma.
Aspen Pharmacare
Ukuxela i-$ 2 yezigidigidi kwingeniso ngo-2016. Njengenye yeenkampani ezimbalwa zonyango eziseMzantsi Afrika, ibone ukukhula ngokugxila kwiimarike ezikhulayo e-Asia. Iyaqhubeka nokukhangela iinkampani ukuba zifumane ukongeza kwipotifoliyo yayo yeyeza.
Aurobindo Pharma
Ivakalise iR8,8 yezigidigidi kwingeniso ngo-2016. I-Aurobindo ibone ukukhula okwenzeka kwiminyaka yamuva kwaye yavula i-565,000-square-foot-based, e-East Windsor, eNew Jersey, ngowama-2017.
UDkt. Reddy's Laboratories
Ivakalise iR8 1.8 billion kwiingeniso ngo-2016.
UDkt. Reddy wasungulwa nguDkt. Anji Reddy ngo-1984 xa wafumana i-Cheminor Drugs.
Cipla
Ingxelo yeeRandi eziyi-1.6 yezigidi ivakaliswe ngo-2016. Isekelwe e-Indiya, i-Cipla nayo inamandla kakhulu eMelika naseMzantsi Afrika.
Apotex
Ingxelo yeeRandi eziyi-1.6 zeeRayibrari ezixeliweyo ngo-2016. I-Apotex ingumninimali omkhulu kunomnye uphando kunye nophuhliso lwenkampani nayiphi na inkampani yezobisi kwiCanada-brand okanye i-generic, ngokwe-website yayo. Unamaprojekthi angaphezulu kwe-1,100 yophando kunye nophuhliso kumazwe angama-50. Ukususela ngo-2008, i-Apotex ityala imali eyi-1 billion yezigidi kuphando kunye nophuhliso, kunye ne-$ 2 yezigidigidi ezicwangcisiweyo ngo-2028. Ithumela kumazwe angaphezu kwe-115 kunye nemimandla kwaye isebenza kumazwe angaphezu kwama-45, ikakhulukazi e-US, Mexico naseIndiya.